• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
  

PubMed=1568228
Robert A. Metcalf, Judith A. Welsh, William P. Bennett, Michael B. Seddon, Teresa A. Lehman, Katarina Pelin-Enlund, Kaija Linnainmaa, Lauri Tammilehto, Karin Mattson, Brenda Isen Gerwin, Curtis Craig Harris;
p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Cancer Res. 52:2610-2615(1992)

CLPUB00243
Katriina Kahlos;
The expression and possible role of manganese superoxide dismutase in malignant pleural mesothelioma.
Thesis PhD (1999); University of Oulu; Oulu; Finland

PubMed=11283936; DOI=10.1002/1097-0142(20010401)91:7<1349::AID-CNCR1138>3.0.CO;2-D
Katriina Kahlos, Ylermi Soini, Raija Sormunen, Riitta Kaarteenaho-Wiik, Paavo Paakko, Kaija Linnainmaa, Vuokko Liisa Kinnula;
Expression and prognostic significance of catalase in malignant mesothelioma.
Cancer 91:1349-1357(2001)

PubMed=12707267; DOI=10.1074/jbc.M302161200
Claire Vivo, Wei-Hong Liu, Virginia Courtney Broaddus;
c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
J. Biol. Chem. 278:25461-25467(2003)

PubMed=23422483
Siham Chaouche-Mazouni, Marie-Christine Copin, Philippe Lassalle, Nemcha Lebaili, Alexis Cortot, Arnaud Scherpereel;
M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo.
In Vivo 27:227-232(2013)